Rutgers, The State University Of New Jersey

This early-phase study tested a two-part treatment for advanced skin cancer. It combined a modified virus injected directly into tumors with an antibody given through an IV. The main goals were to check the safety of this combination and see if it worked better than the antibody …

This early-stage study tested whether combining two immunotherapy drugs (atezolizumab and varlilumab) with targeted radiation could help control advanced non-small cell lung cancer that had stopped responding to standard treatments. The main goal was to check if this three-part c…